Medicskin Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-3.00
-3.00
-3.00
4.00
1.00
-5.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
4.00
3.00
-2.00
-8.00
0.00
7.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
9.00
9.00
3.00
4.00
10.00
15.00
Cash Flow from Investing Activities
0.00
-1.00
-2.00
-1.00
-1.00
38.00
Cash Flow from Financing Activities
1.00
-7.00
-6.00
-17.00
-21.00
-27.00
Net Cash Inflow / Outflow
10.00
0.00
-5.00
-14.00
-12.00
26.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Medicskin Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-3.463
-70.6707942782808
67.00
95.10%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
4.551
-9.91956393507296
13.00
145.88%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
9.549
6.26356113814804
3.00
52.45%
Cash Flow from Investing Activities
-0.845
-12.9987596477855
12.00
93.50%
Cash Flow from Financing Activities
1.755
20.5471260393013
-19.00
-91.46%
Net Cash Inflow / Outflow
10.457
14.0298565220072
-4.00
-25.47%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.002
0.217928992343389
0.00
-100.92%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 0.43% vs 161.71% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
9.55
9.51
0.43%






